Talon Private Wealth LLC Sells 10,006 Shares of Colgate-Palmolive Company $CL

Talon Private Wealth LLC lessened its stake in Colgate-Palmolive Company (NYSE:CL) by 80.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,418 shares of the company’s stock after selling 10,006 shares during the period. Talon Private Wealth LLC’s holdings in Colgate-Palmolive were worth $222,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Brighton Jones LLC boosted its holdings in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP increased its holdings in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares during the period. Schnieders Capital Management LLC. raised its position in Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after purchasing an additional 245 shares in the last quarter. Nebula Research & Development LLC lifted its holdings in shares of Colgate-Palmolive by 165.5% in the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock worth $939,000 after buying an additional 6,437 shares during the period. Finally, Sei Investments Co. lifted its holdings in shares of Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock worth $59,732,000 after buying an additional 116,968 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: A sale could generate cash, simplify Colgate-Palmolive’s brand portfolio and allow management to focus resources on faster-growing or higher-priority categories. The company is reportedly evaluating strategic options for some personal-care assets. Colgate-Palmolive seeks to divest some personal care brands, sources say
• Positive Sentiment: Royal Bank of Canada assigned Colgate-Palmolive an “Outperform” rating, while a separate analyst article described the company as recovering, offering some support for the stock’s longer-term investment case. Colgate-Palmolive Earns Outperform Rating from Royal Bank Of Canada
• Neutral Sentiment: Reports indicate that Goldman Sachs may be involved in exploring potential transactions, but the discussions remain preliminary and there is no announced deal or confirmed buyer. Did Colgate strike a new deal?
• Negative Sentiment: Colgate-Palmolive is reportedly considering the sale of mass-market brands including Softsoap, Irish Spring and Speed Stick. Investors may view the move as a sign that the businesses face limited growth or that management is changing its portfolio strategy, contributing to the stock’s decline. Colgate-Palmolive Stock Dips on Plan to Sell Personal Care Brands

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Wells Fargo & Company raised their price target on Colgate-Palmolive from $92.00 to $95.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 8th. Citigroup upped their price objective on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Monday, August 3rd. UBS Group boosted their price target on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Finally, Barclays upped their price target on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $99.00.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $86.68 on Friday. The stock’s 50-day moving average is $91.34 and its 200 day moving average is $89.61. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The company has a market cap of $69.10 billion, a P/E ratio of 34.40, a PEG ratio of 4.10 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. During the same period in the prior year, the firm posted $0.92 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. Research analysts predict that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Insider Transactions at Colgate-Palmolive

In other news, Director John Cahill sold 4,170 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Corporate insiders own 0.43% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE:CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its products are sold in more than 200 countries and territories through retail stores, e-commerce channels and professional networks.

The company’s portfolio includes Colgate toothpaste, toothbrushes and mouthwashes; Palmolive and Softsoap personal care products; Ajax and other household cleaning products; and Hill’s Science Diet and Prescription Diet pet foods.